Quality assurance in pathology in colorectal cancer screening and diagnosis—European recommendations

Phil Quirke, Mauro Risio, René Lambert, Lawrence von Karsa, Michael Vieth, Phil Quirke, Mauro Risio, René Lambert, Lawrence von Karsa, Michael Vieth

Abstract

In Europe, colorectal cancer is the most common newly diagnosed cancer and the second most common cause of cancer deaths, accounting for approximately 436,000 incident cases and 212,000 deaths in 2008. The potential of high-quality screening to improve control of the disease has been recognized by the Council of the European Union who issued a recommendation on cancer screening in 2003. Multidisciplinary, evidence-based European Guidelines for quality assurance in colorectal cancer screening and diagnosis have recently been developed by experts in a pan-European project coordinated by the International Agency for Research on Cancer. The full guideline document consists of ten chapters and an extensive evidence base. The content of the chapter dealing with pathology in colorectal cancer screening and diagnosis is presented here in order to promote international discussion and collaboration leading to improvements in colorectal cancer screening and diagnosis by making the principles and standards recommended in the new EU Guidelines known to a wider scientific community.

Figures

Fig. 1
Fig. 1
Kikuchi levels of submucosal infiltration modified from Ref. [51]
Fig. 2
Fig. 2
Haggitt levels of invasion in polypoid carcinomas

References

    1. von Karsa L, Anttila A, Ronco G, Ponti A, Malila N, Arbyn M, Segnan N, Castillo-Beltran M, Boniol M, Ferlay J, Hery C, Sauvaget C, Voti L, Autier P (2008) Cancer screening in the European Union—Report on the implementation of the Council Recommendation on cancer screening, First Report. European Commission, Luxembourg
    1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet] Lyon: International Agency for Research on Cancer; 2010.
    1. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348(9040):1472–1477. doi: 10.1016/S0140-6736(96)03386-7.
    1. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348(9040):1467–1471. doi: 10.1016/S0140-6736(96)03430-7.
    1. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota colon cancer control study. N Engl J Med. 1993;328(19):1365–1371. doi: 10.1056/NEJM199305133281901.
    1. Council of the European Union (2003) Council recommendation of 2 December 2003 on cancer screening (2003/878/EC). Off J Eur Union (L 327):34–38
    1. Perry N, Broeders M, de Wolf C, Tornberg S, Holland R, von Karsa L, editors. European guidelines for quality assurance in breast cancer screening and diagnosis. European guidelines for quality assurance in breast cancer screening and diagnosis. 4. Luxembourg: Office for Official Publications of the European Communities; 2006.
    1. European guidelines for quality assurance in cervical cancer screening - Second Edition. Arbyn M, Anttila A, Jordan J, Schenck U, Ronco G, Segnan N, Wiener H, Herbert A, Daniel J, von Karsa L (eds) (2008) European Guidelines for Quality Assurance in Cervical Cancer Screening—Second Edition. Office for Official Publications of the European Communities, Luxembourg
    1. European guidelines for quality assurance in colorectal cancer screening and diagnosis. Segnan N, Patnick J, von Karsa L (eds) (2010) European guidelines for quality assurance in colorectal cancer screening and diagnosis - First edition (in press)
    1. Quirke P, Risio M, Lambert R, Vieth M (2010) Quality assurance in pathology in colorectal cancer screening and diagnosis. In: Segnan N, Patnick J, von Karsa L (eds) European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis - First edition (in press)
    1. Vieth M, Quirke P, Lambert R, von Karsa L, Risio M (2010) Annotations of colorectal lesions. In: Segnan N, Patnick J, von Karsa L (eds) European guidelines for quality assurance in colorectal cancer screening and diagnosis - First edition (in press)
    1. Snover DC, Jass JR, Fenoglio-Preiser C, Batts KP. Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol. 2005;124(3):380–391. doi: 10.1309/V2EPTPLJRB3FGHJL.
    1. Minozzi S, Armaroli P, Segnan N (2010) Principles of evidence assessment and methods for reaching recommendations. In: Segnan N, Patnick J, von Karsa L (eds) European guidelines for quality assurance in colorectal cancer screening and diagnosis - First Edition, pp LIII–LXI (in press)
    1. Greenhalgh T (1997) Why read papers at all? In: How to read a paper. The basics of evidence-based medicine. BMJ Books, London. pp 1–14
    1. O’Connor D, Green S, Higgins JPT. Defining the review question and developing criteria for including studies. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions (Wiley Cochrane Series) (Hardcover) UK: Wiley-Blackwell; 2008.
    1. Richardson WS, Wilson MC, Nishikawa J, Hayward RS. The well-built clinical question: a key to evidence-based decisions. ACP J Club. 1995;123(3):A12–A13.
    1. Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, Porter AC, Tugwell P, Moher D, Bouter LM. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007;7:10. doi: 10.1186/1471-2288-7-10.
    1. Higgins JPT, Altman DG. Assessing risk of bias in included studies. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions. UK: Wiley-Blackwell; 2008.
    1. Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P (2010) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: . Accessed 16 Sept 2010
    1. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25. doi: 10.1186/1471-2288-3-25.
    1. Kudo S, Lambert R, Allen JI, Fujii H, Fujii T, Kashida H, Matsuda T, Mori M, Saito H, Shimoda T, Tanaka S, Watanabe H, Sung JJ, Feld AD, Inadomi JM, O’Brien MJ, Lieberman DA, Ransohoff DF, Soetikno RM, Triadafilopoulos G, Zauber A, Teixeira CR, Rey JF, Jaramillo E, Rubio CA, Van GA, Jung M, Vieth M, Jass JR, Hurlstone PD. Nonpolypoid neoplastic lesions of the colorectal mucosa. Gastrointest Endosc. 2008;68(4 Suppl):S3–S47. doi: 10.1016/j.gie.2008.07.052.
    1. Tominaga K, Fujinuma S, Endo T, Saida Y, Takahashi K, Maetani I. Efficacy of the revised Vienna classification for diagnosing colorectal epithelial neoplasias. World J Gastroenterol. 2009;15(19):2351–2356. doi: 10.3748/wjg.15.2351.
    1. WHO . Pathology and genetics of tumours in the digestive system. Carcinoma of the colon and rectum. In: Hamilton SR, Aaltonen LA, editors. World health organization international histological classification of tumours. Lyon: IARC; 2000. pp. 105–119.
    1. Schlemper RJ, Riddell RH, Kato Y, Borchard F, Cooper HS, Dawsey SM, Dixon MF, Fenoglio-Preiser CM, Flejou JF, Geboes K, Hattori T, Hirota T, Itabashi M, Iwafuchi M, Iwashita A, Kim YI, Kirchner T, Klimpfinger M, Koike M, Lauwers GY, Lewin KJ, Oberhuber G, Offner F, Price AB, Rubio CA, Shimizu M, Shimoda T, Sipponen P, Solcia E, Stolte M, Watanabe H, Yamabe H (2000) The Vienna classification of gastrointestinal epithelial neoplasia. Gut 47(2):251–255
    1. Schlemper RJ, Kato Y, Stolte M (2001) Review of histological classifications of gastrointestinal epithelial neoplasia: differences in diagnosis of early carcinomas between Japanese and Western pathologists. J Gastroenterol 36(7):445–456
    1. Dixon MF. Gastrointestinal epithelial neoplasia: Vienna revisited. Gut. 2002;51(1):130–131. doi: 10.1136/gut.51.1.130.
    1. Stolte M. The new Vienna classification of epithelial neoplasia of the gastrointestinal tract: advantages and disadvantages. Virchows Arch. 2003;442(2):99–106.
    1. Suzuki N, Price AB, Talbot IC, Wakasa K, Arakawa T, Ishiguro S, Fraser C, Saunders BP. Flat colorectal neoplasms and the impact of the revised Vienna Classification on their reporting: a case-control study in UK and Japanese patients. Scand. J Gastroenterol. 2006;41(7):812–819.
    1. Schoen RE, Gerber LD, Margulies C. The pathologic measurement of polyp size is preferable to the endoscopic estimate. Gastrointest Endosc. 1997;46(6):492–496. doi: 10.1016/S0016-5107(97)70002-6.
    1. EC Working Group on Breast Screening Pathology . Quality assurance guidelines for pathology. Open biopsy and resection specimens. In: Perry N, Broeders M, de Wolf C, Tornberg S, Holland R, von Karsa L, editors. European guidelines for quality assurance in breast cancer screening and diagnosis. 4. Luxembourg: Office for Official Publications of the European Communities; 2006.
    1. The Paris Classification The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc. 2003;58(6 Suppl):S3–S43.
    1. Soetikno RM, Kaltenbach T, Rouse RV, Park W, Maheshwari A, Sato T, Matsui S, Friedland S. Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA. 2008;299(9):1027–1035. doi: 10.1001/jama.299.9.1027.
    1. Longacre TA, Fenoglio-Preiser CM. Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol. 1990;14(6):524–537. doi: 10.1097/00000478-199006000-00003.
    1. Atkin W, Valori R, Kuipers EJ, Hoff G, Senore C, Segnan N, Jover R, Schmiegel W, Lambert R, Pox C (2010) Colonoscopic surveillance after adenoma removal. In: Segnan N, Patnick J, von Karsa L (eds) European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis - First edition (in press)
    1. Jass JR, Baker K, Zlobec I, Higuchi T, Barker M, Buchanan D, Young J. Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a ‘fusion’ pathway to colorectal cancer. Histopathology. 2006;49(2):121–131. doi: 10.1111/j.1365-2559.2006.02466.x.
    1. Fenger C, Bak M, Kronborg O, Svanholm H (1990) Observer reproducibility in grading dysplasia in colorectal adenomas: comparison between two different grading systems. J Clin Pathol 43(4):320–324
    1. Jass JR, Williams CB, Bussey HJ, Morson BC. Juvenile polyposis—a precancerous condition. Histopathology. 1988;13(6):619–630. doi: 10.1111/j.1365-2559.1988.tb02093.x.
    1. Burt R, Jass J. Hyperplastic polyposis. World health organisation classification of tumours: pathology and genetics of tumours of the digestive system. Lyon: IARC; 2000. pp. 135–136.
    1. WHO . Histological typing of intestinal tumours. In: Jass JR, Sobin LH, editors. World health organisation international histological classification of tumours. 2. Berlin: Springer-Verlag; 1989. p. 30.
    1. Sobin LH, Wittekind C, editors. TNM classification of malignant tumours. 5. New York: Wiley; 1997.
    1. Sobin LH, Wittekind C, editors. TNM Classification of malignant tumours. 6. New Jersey: Wiley; 2002.
    1. TNM Classification of Malignant Tumours, 7th Edition Sobin LH, Gospodarowicz MK, Wittekind C (eds) (2009) TNM Classification of Malignant Tumours, 7th Edition. Wiley-Blackwell, New York
    1. Muto T, Bussey HJ, Morson BC. Pseudo-carcinomatous invasion in adenomatous polyps of the colon and rectum. J Clin Pathol. 1973;26(1):25–31. doi: 10.1136/jcp.26.1.25.
    1. Cooper HS, Deppisch LM, Gourley WK, Kahn EI, Lev R, Manley PN, Pascal RR, Qizilbash AH, Rickert RR, Silverman JF. Endoscopically removed malignant colorectal polyps: clinicopathologic correlations. Gastroenterology. 1995;108(6):1657–1665. doi: 10.1016/0016-5085(95)90126-4.
    1. Coverlizza S, Risio M, Ferrari A, Fenoglio-Preiser CM, Rossini FP. Colorectal adenomas containing invasive carcinoma. Pathologic assessment of lymph node metastatic potential. Cancer. 1989;64(9):1937–1947. doi: 10.1002/1097-0142(19891101)64:9<1937::AID-CNCR2820640929>;2-X.
    1. Hassan C, Zullo A, Risio M, Rossini FP, Morini S. Histologic risk factors and clinical outcome in colorectal malignant polyp: a pooled-data analysis. Dis Colon Rectum. 2005;48(8):1588–1596. doi: 10.1007/s10350-005-0063-3.
    1. Volk EE, Goldblum JR, Petras RE, Carey WD, Fazio VW. Management and outcome of patients with invasive carcinoma arising in colorectal polyps. Gastroenterology. 1995;109(6):1801–1807. doi: 10.1016/0016-5085(95)90746-7.
    1. Blumberg D, Paty PB, Guillem JG, Picon AI, Minsky BD, Wong WD, Cohen AM (1999) All patients with small intramural rectal cancers are at risk for lymph node metastasis. Dis Colon Rectum 42(7):881–885
    1. Kikuchi R, Takano M, Takagi K, Fujimoto N, Nozaki R, Fujiyoshi T, Uchida Y. Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum. 1995;38(12):1286–1295. doi: 10.1007/BF02049154.
    1. Kudo S. Endoscopic mucosal resection of flat and depressed types of early colorectal cancer. Endoscopy. 1993;25(7):455–461. doi: 10.1055/s-2007-1010367.
    1. Nascimbeni R, Burgart LJ, Nivatvongs S, Larson DR. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum. 2002;45(2):200–206. doi: 10.1007/s10350-004-6147-7.
    1. Haggitt RC, Glotzbach RE, Soffer EE, Wruble LD. Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology. 1985;89(2):328–336.
    1. Ueno H, Mochizuki H, Hashiguchi Y, Shimazaki H, Aida S, Hase K, Matsukuma S, Kanai T, Kurihara H, Ozawa K, Yoshimura K, Bekku S. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology. 2004;127(2):385–394. doi: 10.1053/j.gastro.2004.04.022.
    1. Washington MK, Berlin J, Branton P, Burgart LJ, Carter DK, Fitzgibbons PL, Halling K, Frankel W, Jessup J, Kakar S, Minsky B, Nakhleh R, Compton CC. Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum. Arch Pathol Lab Med. 2009;133(10):1539–1551.
    1. Cooper HS, Deppisch LM, Kahn EI, Lev R, Manley PN, Pascal RR, Qizilbash AH, Rickert RR, Silverman JF, Wirman JA. Pathology of the malignant colorectal polyp. Hum Pathol. 1998;29(1):15–26. doi: 10.1016/S0046-8177(98)90385-9.
    1. Masaki T, Matsuoka H, Sugiyama M, Abe N, Sakamoto A, Atomi Y. Actual number of tumor budding as a new tool for the individualization of treatment of T1 colorectal carcinomas. J Gastroenterol Hepatol. 2006;21(7):1115–1121. doi: 10.1111/j.1440-1746.2006.04073.x.
    1. Sakuragi M, Togashi K, Konishi F, Koinuma K, Kawamura Y, Okada M, Nagai H. Predictive factors for lymph node metastasis in T1 stage colorectal carcinomas. Dis Colon Rectum. 2003;46(12):1626–1632. doi: 10.1007/BF02660767.
    1. Deinlein P, Reulbach U, Stolte M, Vieth M. Risk factors for lymphatic metastasis from pT1 colorectal adenocarcinoma. Pathologe. 2003;24(5):387–393. doi: 10.1007/s00292-003-0632-y.
    1. Wang HS, Liang WY, Lin TC, Chen WS, Jiang JK, Yang SH, Chang SC, Lin JK. Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis. Dis Colon Rectum. 2005;48(6):1182–1192. doi: 10.1007/s10350-004-0935-y.
    1. Prall F. Tumour budding in colorectal carcinoma. Histopathology. 2007;50(1):151–162. doi: 10.1111/j.1365-2559.2006.02551.x.
    1. Okuyama T, Oya M, Ishikawa H. Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma. Dis Colon Rectum. 2002;45(5):628–634. doi: 10.1007/s10350-004-6259-0.
    1. Jass JR, O’Brien J, Riddell RH, Snover DC. Recommendations for the reporting of surgically resected specimens of colorectal carcinoma: association of directors of anatomic and surgical pathology. Am J Clin Pathol. 2008;129(1):13–23. doi: 10.1309/6UHNC7MAD8KWNAWC.
    1. Quirke P, Cuvelier C, Ensari A, Glimelius B, Laurberg S, Ortiz H, Piard F, Punt CJA, Glenthoj A, Pennickx F, Seymour M, Valentini V, Williams G, Nagtegaal I (2010) Evidence-based medicine: the time has come to set standards for staging. J Pathol 221(4):357–360
    1. Quirke P, Williams GT, Ectors N, Ensari A, Piard F, Nagtegaal I. The future of the TNM staging system in colorectal cancer: time for a debate? Lancet Oncol. 2007;8(7):651–657. doi: 10.1016/S1470-2045(07)70205-X.
    1. Beattie GC, McAdam TK, Elliott S, Sloan JM, Irwin ST. Improvement in quality of colorectal cancer pathology reporting with a standardized proforma—a comparative study. Colorectal Dis. 2003;5(6):558–562. doi: 10.1046/j.1463-1318.2003.00466.x.
    1. Branston LK, Greening S, Newcombe RG, Daoud R, Abraham JM, Wood F, Dallimore NS, Steward J, Rogers C, Williams GT. The implementation of guidelines and computerised forms improves the completeness of cancer pathology reporting. The CROPS project: a randomised controlled trial in pathology. Eur J Cancer. 2002;38(6):764–772. doi: 10.1016/S0959-8049(01)00258-1.
    1. Eon Y, Le Douy JY, Lamer B, Battini J, Bretagne JF. Quality and completeness of histopathology reports of rectal cancer resections. Results of an audit in Brittany. Gastroentérol Clin Biol. 2006;30(2):235–240. doi: 10.1016/S0399-8320(06)73159-1.
    1. Oppong C, Robertson N, Sherwood A, Brodribb J. The use of a proforma improves colorectal cancer pathology reporting. Ann R Coll Surg Engl. 2002;84(4):290.
    1. Quirke P, Williams GT. Minimum dataset for colorectal cancer histopathology reports. London: Royal College of Pathologists; 1998.
    1. Rigby K, Brown SR, Lakin G, Balsitis M, Hosie KB. The use of a proforma improves colorectal cancer pathology reporting. Ann R Coll Surg Engl. 1999;81(6):401–403.
    1. Wei JT, Miller EA, Woosley JT, Martin CF, Sandler RS. Quality of colon carcinoma pathology reporting: a process of care study. Cancer. 2004;100(6):1262–1267. doi: 10.1002/cncr.20090.
    1. Cross SS, Feeley KM, Angel CA (1998) The effect of four interventions on the informational content of histopathology reports of resected colorectal carcinomas. J Clin Pathol 51(6):481-482
    1. Williams GT, Quirke P, Shepherd NA (2007) Dataset for colorectal cancer (2nd edition) - Appendix D: Proforma for local excision specimens. Available at: . Accessed 16 Sept 2010
    1. Williams GT, Quirke P, Shepherd NA (2007) Dataset for colorectal cancer (2nd edition) - Appendix C: Proforma for colorectal cancer resections. Available at: . Accessed 16 Sept 2010
    1. Williams GT, Quirke P, Shepherd NA (2007) Dataset for colorectal cancer (2nd edition). Available at: . Accessed 16 Sept 2010
    1. NHS Bowel Cancer Screening Programme (2007) Reporting lesions in the NHS bowel cancer screening programme - guidelines from the bowel cancer screening programme pathology group. Available at: . Accessed 16 Sept 2010
    1. SIGN (2003) Scottish intercollegiate guidelines network—guidelines for the management of colorectal cancer. Available at: . Accessed 16 Sept 2010
    1. Vereniging integrale kankercentra (2008) Rectal cancer. Nation-wide guideline, Version: 2.0. Available at: . Accessed 16 Sept 2010
    1. Vereniging integrale kankercentra (2008) Colon cancer. Nation-wide guideline, Version: 2.0. Available at: . Accessed 16 Sept 2010
    1. Schmiegel W, Reinacher-Schick A, Arnold D, Graeven U, Heinemann V, Porschen R, Riemann J, Rodel C, Sauer R, Wieser M, Schmitt W, Schmoll HJ, Seufferlein T, Kopp I, Pox C. [Update S3-guideline “colorectal cancer” 2008] Z Gastroenterol. 2008;46(8):799–840. doi: 10.1055/s-2008-1027726.
    1. Risio M, Baccarini P, Casson P, Clemente C, Ederle A, Fiocca R, Senore C, Sonzogno A, Tomezzoli A, Zamboni G. Histopathologic diagnosis in colorectal cancer screening: guidelines. Pathologica. 2006;98(3):171–174.
    1. DAP-TM-30 (2007) Leitfaden zur Interpretation der Anforderungen der DIN EN ISO/IEC 17020 : 2004 und technische Kriterien fuer deren Anwendung zur Akkreditierung in der Pathologie/Neuropathologie. Available at: :11. Accessed 16 Sept 2010
    1. Risio M, Bussolati G, Senore C, Vigna S, Frangipane E, Segnan N, Cassoni P (2010) Virtual microscopy for histology quality assurance of screen-detected polyps. J Clin Pathol 63(10):916-920
    1. Roecken C, Manke H. Akkreditierung in der Pathologie. Systemdarstellung und Dokumentation der Taetigkeiten in der Pathologie. Pathologe. 2010;31:268–278. doi: 10.1007/s00292-009-1237-x.
    1. Gondal G, Grotmol T, Hofstad B, Bretthauer M, Eide TJ, Hoff G. Biopsy of colorectal polyps is not adequate for grading of neoplasia. Endoscopy. 2005;37(12):1193–1197. doi: 10.1055/s-2005-921031.
    1. Torlakovic EE, Gomez JD, Driman DK, Parfitt JR, Wang C, Benerjee T, Snover DC. Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA) Am J Surg Pathol. 2008;32(1):21–29. doi: 10.1097/PAS.0b013e318157f002.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다